Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Juan F, Mosley"'
1
Neurotoxicities in the treatment of HIV between dolutegravir, rilpivirine and dolutegravir/rilpivirine: a meta-analysis
Autor: Andrea V Fuentes, Catherine Harrington, Joshua Caballero, Anthony Allen Reeves, Jennifer E. Thomas, Juan F Mosley
Publikováno v: Sexually Transmitted Infections. 97:261-267
ObjectiveTo assess the risk of neuropsychiatric adverse effects (ie, depression, anxiety, insomnia, dizziness, suicidal behaviour) among patients treated with rilpivirine, dolutegravir and dolutegravir/rilpivirine.DesignThis is a systematic review an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94f80cae930ced9a6cc0d7aa212aa207
https://doi.org/10.1136/sextrans-2020-054821
Zobrazit plný text záznamu
3
Prevention Strategies Against HIV Transmission: A Proactive Approach
Autor: Jovan D. Miles, Marcus M. Gurley, Emily Everton, Linh D. Phan, Antonio J. Carrion, April S. Prather, Lillian L. Smith, Juan F. Mosley
Publikováno v: Journal of pharmacy practice. 31(1)
Human immunodeficiency virus (HIV) has now transformed into a manageable chronic condition. Highly active antiretroviral therapy (HAART) has proven efficacious at controlling the disease progression. Based on compelling evidence, the Department of He
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05fa555081a3dc804ba4cdb144799dfc
https://pubmed.ncbi.nlm.nih.gov/29278971
Zobrazit plný text záznamu
4
Brand versus generic medications: A disease state approach to identify patients’ perceptions and concerns
Autor: Megan Ford, Chase Stefanelli, Jonathan Courtney, Juan F. Mosley, Lillian L. Smith
Publikováno v: Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector. 12:102-108
Background Medication cost does not solely dictate patient preference of brand name or generic medications. However, few studies have been completed to assess the influence of other factors, such as demographics and chronic diseases. Methods Response
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dcb11a4c8e5287fb331c26be7882479d
https://doi.org/10.1177/1741134316644007
Zobrazit plný text záznamu
5
Dulaglutide (Trulicity): The Third Once-Weekly GLP-1 Agonist
Autor: Lillian L, Smith, Juan F, Mosley, Crystal, Parke, Jamal, Brown, Lillian S, Barris, Linh D, Phan
Publikováno v: PT : a peer-reviewed journal for formulary management. 41(6)
Dulaglutide (Trulicity): the third once-weekly GLP-1 agonist for type-2 diabetes.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::182c270fdb3d947d46565e14bbe2dd18
https://pubmed.ncbi.nlm.nih.gov/27313432
Zobrazit plný text záznamu
6
The New Face of Hyperlipidemia Management: Proprotein Convertase Subtilisin/Kexin Inhibitors (PCSK-9) and Their Emergent Role As An Alternative To Statin Therapy
Autor: Juan F. Mosley, Luke Caswell, Lillian L. Smith, Jarah Yates
Publikováno v: Journal of Pharmacy & Pharmaceutical Sciences, Vol 19, Iss 1 (2016)
This review analyzes Proprotein Convertase Subtilisin/Kexin 9 inhibitors (PCSK-9), a new medication class that has arisen in the last year to combat hypercholesterolemia. They are targeted towards patients who are unable to achieve acceptable low den
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3a683cc4b6e652a34f23d48fe6c0a62
https://pubmed.ncbi.nlm.nih.gov/27096698
Zobrazit plný text záznamu
7
Impact of pharmacy-led medication reconciliation on medication errors during transition in the hospital setting
Autor: Lillian L. Smith, Linh D. Phan, Ernie Cyr, Sonia Lott, Opeyemi Komolafe, Abdullah Islami, Juan F. Mosley, Emily Everton, Ramid Amin
Publikováno v: Pharmacy Practice
Pharmacy Practice, Vol 13, Iss 4, p 634 (2015)
Pharmacy Practice (Granada) v.13 n.4 2015
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Objective: To assess if the pharmacy department should be more involved in the medication reconciliation process to assist in the reduction of medication errors that occur during transition of care points in the hospital setting. Methods: This was an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e3090f025eb76d6ec1c352ec2d7a975
http://europepmc.org/articles/PMC4696120
Zobrazit plný text záznamu
8
Sodium-Glucose Linked Transporter 2 (SGLT2) Inhibitors in the Management Of Type-2 Diabetes: A Drug Class Overview
Autor: Juan F, Mosley, Lillian, Smith, Emily, Everton, Chris, Fellner
Publikováno v: PT : a peer-reviewed journal for formulary management. 40(7)
Sodium-glucose linked transporter 2 inhibitors limit the reabsorption of glucose from glomerular filtrate in the kidneys, reducing blood glucose levels in patients with type- 2 diabetes. This article is meant to evaluate this class of medications for
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::dc7bb54586032c9d00e7c1021f547758
https://pubmed.ncbi.nlm.nih.gov/26185406
Zobrazit plný text záznamu
9
An overview of upcoming changes in pregnancy and lactation labeling information
Autor: Juan F. Mosley, Megan D. Dezan, Lillian L. Smith
Publikováno v: Pharmacy Practice
Pharmacy Practice (Granada) v.13 n.2 2015
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Background: Many medications can be used safely and effectively to provide health benefits for disease state management during pregnancy with minimal risk to the fetus or mother. Today nine out of ten women take at least one medication during pregnan
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca20ee6a397b5b49c7433c7289461776
https://pubmed.ncbi.nlm.nih.gov/26131048
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje